NovMetaPharma Co., Ltd. (XKON:229500)

NovMetaPharma Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2014	FY 2013
Period Ending	Dec 31, 2014	Dec 31, 2013
Cash & Equivalents	2,496	1,408
Short-Term Investments	1,000	-
Cash & Short-Term Investments	3,496	1,408
Cash Growth	148.20%	-
Accounts Receivable	-	138.6
Other Receivables	48.81	10.3
Receivables	48.81	148.9
Inventory	450.52	3.21
Other Current Assets	1.09	692.23
Total Current Assets	3,996	2,253
Property, Plant & Equipment	70.39	9.95
Other Intangible Assets	34.46	58.02
Other Long-Term Assets	1,426	20.08
Total Assets	5,527	2,341
Accounts Payable	61.24	18.65
Accrued Expenses	56.43	28.21
Other Current Liabilities	6.19	38.17
Total Current Liabilities	123.87	85.03
Other Long-Term Liabilities	0	0
Total Liabilities	205.55	130.41
Common Stock	1,705	1,490
Additional Paid-In Capital	3,813	1,325
Retained Earnings	-196.56	-604.59
Shareholders' Equity	5,321	2,210
Total Liabilities & Equity	5,527	2,341
Net Cash (Debt)	3,496	1,408
Net Cash Growth	148.20%	-
Net Cash Per Share	1028.08	502.45
Filing Date Shares Outstanding	3.4	2.8
Total Common Shares Outstanding	3.4	2.8
Working Capital	3,872	2,168
Book Value Per Share	1564.89	788.55
Tangible Book Value	5,287	2,152
Tangible Book Value Per Share	1554.76	767.85
Machinery	112.15	39.7

Source: S&P Global Market Intelligence. Standard template. Financial Sources.